Michael S. Wyzga

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Christine Fox, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael S. Wyzga:

Form 4 holding Director

Mereo BioPharma Group plc

Security class
Share Options (Right to buy)
Shares / value
66,000
Estimated value
$55,550
Report date
26 Feb 2026
Price
$1.01
Ownership
Direct
Underlying class
American Depositary Shares
Underlying amount
Form 4 holding Director

Invivyd, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
50,000
Estimated value
Report date
23 May 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Tvardi Therapeutics, Inc.

Security class
Stock Option (right to buy)
Shares / value
12,000
Estimated value
Report date
17 Apr 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

LogicBio Therapeutics, Inc.

Security class
Stock Option (right to buy)
Shares / value
0
Estimated value
Report date
16 Nov 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Michael S. Wyzga

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .